Author details

Full Name

Haiwei Mou

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37229906	Patient-derived melanoma organoid models facilitate the assessment of immunotherapies.	EBioMedicine	2023
36395073	The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice.	Reproduction	2023
36241367	A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals.	RNA	2022
34529935	Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.	Cell Stem Cell	2021
32452550	YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte-Like Cells.	Hepatology	2021
31188495	Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.	Hepatology	2020
31900453	Evolutionarily conserved pachytene piRNA loci are highly divergent among modern humans.	Nat Ecol Evol	2020
30987660	CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.	Genome Medicine	2019
30102296	Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice.	Nature Biotechnology	2018
30400804	Understanding and repurposing CRISPR-mediated alternative splicing.		2018
30148885	The temporal landscape of recursive splicing during Pol II transcription elongation in human cells.	PLoS Genet	2018
27956228	Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.	Gastroenterology	2017
28615073	CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.	Genome Biol	2017
28320962	Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.	Proc Natl Acad Sci U S A	2017
28697339	Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma.	Cancer Cell	2017
29131148	Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.	Nature Biotechnology	2017
26086867	Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.	Hum Gene Ther	2015
26018130	A versatile reporter system for CRISPR-mediated chromosomal rearrangements.	Genome Biol	2015
26060510	Precision cancer mouse models through genome editing with CRISPR-Cas9.	Genome Medicine	2015
26004228	Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis.	Molecular Cell	2015
23246487	Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway.	International Journal of Biochemistry and Cell Biology	2013
23059759	A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.	Cancer Letters	2013
21761148	Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells.	Inflammation	2012
21935471	Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.	PLoS ONE	2011
21664946	Upregulation of pancreatic derived factor (FAM3B) expression in pancreatic Î²-cells by MCP-1 (CCL2).	Molecular and Cellular Endocrinology	2011
20712904	Resveratrol differentially modulates inflammatory responses of microglia and astrocytes.	Journal of Neuroinflammation	2010
18045224	Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.	Protein and Peptide Letters	2007